ResearcherKobe UniversityNo recent work listed

Meiko Nishimura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7285-9426; OpenAlex author ID A5071516345. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper

Papers 1

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancrea… Co-author DOI 10.1007/s00280-016-3026-6 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hironobu Minami · 1 shared paper, 2016 · strength 0.05
- Paper The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung d… DOI 10.1007/s00280-016-3026-6 ↗
Akihito Tsuji · 1 shared paper, 2016 · strength 0.05
- Paper The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung d… DOI 10.1007/s00280-016-3026-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.